167 related articles for article (PubMed ID: 28888621)
21. Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.
Kantarjian HM; Fenaux P; Sekeres MA; Szer J; Platzbecker U; Kuendgen A; Gaidano G; Wiktor-Jedrzejczak W; Carpenter N; Mehta B; Franklin J; Giagounidis A
Lancet Haematol; 2018 Mar; 5(3):e117-e126. PubMed ID: 29396092
[TBL] [Abstract][Full Text] [Related]
22. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
24. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
[No Abstract] [Full Text] [Related]
25. Successful management of acute myeloid leukemia transformed from myelodysplastic syndromes in an elderly patient aged over 80 years old by ultralow dose decitabine combined with amifostine and autologous CIK cells.
Yang B; Wang HT; Cai LL; Zhao Y; Chi XH; Zhu HL; Ran HH; Yang Y; Yu RL; Li SW; Lu XC
Ann Hematol; 2014 Jul; 93(7):1233-5. PubMed ID: 24240975
[No Abstract] [Full Text] [Related]
26. Quality of life from the perspective of the patient with acute myeloid leukemia.
Buckley SA; Jimenez-Sahagun D; Othus M; Walter RB; Lee SJ
Cancer; 2018 Jan; 124(1):145-152. PubMed ID: 28881384
[TBL] [Abstract][Full Text] [Related]
27. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
[TBL] [Abstract][Full Text] [Related]
28. Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times.
Patel SS; Gerds AT
Curr Hematol Malig Rep; 2017 Oct; 12(5):455-460. PubMed ID: 28822056
[TBL] [Abstract][Full Text] [Related]
29. [Hematology in the elderly patient: is there progress? 42nd Congress of the French National Society of Internal Medicine in Provence--8-10 June 2000].
Renou P
Presse Med; 2000 Sep; 29(27):1517-9. PubMed ID: 11045123
[No Abstract] [Full Text] [Related]
30. Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.
Koenecke C; Göhring G; de Wreede LC; van Biezen A; Scheid C; Volin L; Maertens J; Finke J; Schaap N; Robin M; Passweg J; Cornelissen J; Beelen D; Heuser M; de Witte T; Kröger N;
Haematologica; 2015 Mar; 100(3):400-8. PubMed ID: 25552702
[TBL] [Abstract][Full Text] [Related]
31. Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.
Mustafa Ali M; Abounader DM; Rybicki LA; Yurch MA; Starn J; Ferraro C; Winslow V; Hamilton BK; Gerds AT; Liu H; Dean R; Hill BT; Pohlman B; Andresen S; Hanna R; Kalaycio M; Bolwell BJ; Majhail NS; Sobecks RM
Biol Blood Marrow Transplant; 2017 May; 23(5):776-781. PubMed ID: 28108271
[TBL] [Abstract][Full Text] [Related]
32. Advances in stem cell transplantation: making it better and safer.
Giralt S
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S293-5. PubMed ID: 19778855
[TBL] [Abstract][Full Text] [Related]
33. Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
Akpan IJ; Osman AEG; Drazer MW; Godley LA
Curr Hematol Malig Rep; 2018 Dec; 13(6):426-434. PubMed ID: 30259338
[TBL] [Abstract][Full Text] [Related]
34. Characteristics and Outcomes of Second Malignant Neoplasms after Childhood Cancer Treatment: Multi-Center Retrospective Survey.
Koh KN; Yoo KH; Im HJ; Sung KW; Koo HH; Kim HS; Han JW; Yoon JH; Park HJ; Park BK; Baek HJ; Kook H; Lee JA; Lee JM; Lee KC; Kim SK; Park M; Lee YH; Lyu CJ; Seo JJ
J Korean Med Sci; 2016 Aug; 31(8):1254-61. PubMed ID: 27478336
[TBL] [Abstract][Full Text] [Related]
35. Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.
Crawford R; Sully K; Conroy R; Johnson C; Doward L; Bell T; Welch V; Peloquin F; Gater A
Patient; 2020 Feb; 13(1):83-102. PubMed ID: 31456136
[TBL] [Abstract][Full Text] [Related]
36. Outcome of acute myeloid leukemia and high-risk myelodysplastic syndrome according to health insurance status.
Al-Ameri A; Anand A; Abdelfatah M; Kanaan Z; Hammonds T; Haller N; Cherry M
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):509-13. PubMed ID: 25108681
[TBL] [Abstract][Full Text] [Related]
37. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
Ossenkoppele GJ; van de Loosdrecht AA; Schuurhuis GJ
Br J Haematol; 2011 May; 153(4):421-36. PubMed ID: 21385170
[TBL] [Abstract][Full Text] [Related]
38. Measuring quality of life in acute myeloid leukemia: limitations and future directions.
Buckley SA; Lee SJ; Walter RB
Expert Rev Hematol; 2016 Sep; 9(9):821-3. PubMed ID: 27389467
[No Abstract] [Full Text] [Related]
39. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
[TBL] [Abstract][Full Text] [Related]
40. Bibliography. Current world literature. Leukemia.
Curr Opin Oncol; 2000 Jan; 12(1):B1-12. PubMed ID: 10687737
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
